Alison Mosca - 13 Nov 2025 Form 4 Insider Report for Clene Inc. (CLNN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Nov 2025, 16:46:41 UTC
Prior SEC filing
15 Aug 2025
Next SEC filing
13 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jerome T. Miraglia POA

Key filing fact

Alison Mosca filed Form 4 for Clene Inc. (CLNN) on 14 Nov 2025.

Key facts

  • This page summarizes Alison Mosca's Form 4 filing for Clene Inc. (CLNN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 14 Nov 2025, 16:46.

Change

  • Previous filing in this sequence was filed on 15 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001835537 Primary reporting owner

Mosca Alison

Relationship
Director
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Signature
/s/ Jerome T. Miraglia POA
Signature date
14 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLNN transaction Derivative

stock option

Award

Transaction value
$0
Shares
+2,887
Change %
Price
$0.000000
Shares after
2,887
Date
13 Nov 2025
Ownership
Direct
Underlying class
common stock
Underlying amount
2,887
Exercise price
$7.30
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted on November 13, 2025 as an option for 2,887 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .